Both non-transfusion-dependent and transfusion dependent cohorts met their respective primary and secondary endpointsPRINCETON, N.J.--(BUSINESS WIRE)--$BMY #BMS--Bristol Myers Squibb (NYSE: BMY) today ...

Explore the crucial differences between battery swapping and rapid charging for electric vehicles (EVs), examining their ...

Junk also inquired about the revenue weighting for 2026. Rouquet responded that the second half of 2026 is expected to be stronger due to backloaded launches, especially in China and with Toyota, and ...

Electra announces a major milestone with the successful validation of its EVE‑Ai™ Adaptive Controls platform, enabling ...

Starting biologic therapy at diagnosis, rather than escalating later, may significantly reduce complications and ...

Iberdomide has the potential to be the first approved CELMoD agentThe U.S. FDA has granted Breakthrough Therapy Designation and Priority Review for this indication and assigned a target action date of ...

Novo Nordisk advanced coramitug into the Phase III CLEOPATTRA trial, evaluating 1,280 patients with amyloid transthyretin cardiomyopathy or ATTR-CM. This decision was informed by results from their ...

E-Technologies Lab Inc. introduces the Z-Viper with 2000W Peak Power and the Z-Python with 2500W Peak Power. The goal ...

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q4 2025 Earnings Call Transcript February 17, 2026 Halozyme Therapeutics, Inc.

Here’s an explainer on the 80% EV charging rule and why owners should follow it to use their electric vehicles more ...

Princeton, New Jersey Thursday, February 19, 2026, 11:00 Hrs [IST] ...

Suppliers are investing in production to support deals with AstraZeneca, Bayer and other drugmakers that are advancing radioisotope-based cancer therapies.